Efficacy of octenidine dihydrochloride and 2-phenoxyethanol in the topical treatment of inflammatory acne

Acta Dermatovenerologica Alpina, Pannonica et Adriatica

Volumn 17, Issue 3, 2008, Pages 139-143

  Mayr Kanhäuser, Sigrid ^a   Kränke, Birger ^a   Aberer, Werner ^a  

^a UNIVERSITY OF GRAZ   (Austria)

Author keywords

2 phenoxyethanol; Acne; Antibiotic resistance; Octenidine dihydrochloride

Indexed keywords

2 PHENOXYETHANOL; ANTI ACNE AGENT; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; OCTENIDINE; OCTENISEPT; UNCLASSIFIED DRUG;

ACNE; ADOLESCENT; ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; COST EFFECTIVENESS ANALYSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; ERYTHEMA; FACE DISORDER; FEMALE; FLUORESCENCE ANALYSIS; HUMAN; MALE; MONOTHERAPY; OUTCOME ASSESSMENT; PAPULE; PHOTOTHERAPY; PUSTULE; SKIN BURNING SENSATION; SKIN EXAMINATION; SKIN INFLAMMATION; SKIN IRRITATION; SKIN MANIFESTATION; SKIN TOXICITY; TREATMENT DURATION;

ACNE VULGARIS; ADMINISTRATION, CUTANEOUS; ADOLESCENT; ANTI-INFECTIVE AGENTS, LOCAL; DRUG COMBINATIONS; ETHYLENE GLYCOLS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; PILOT PROJECTS; PYRIDINES; TREATMENT OUTCOME; YOUNG ADULT;

EID: 55049141485     PISSN: 13184458     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Brown SK, Shalita AR. Acne vulgaris. Lancet. 1998;351:1871-6.
2. Eady EA, Cove JH, Holland KT, Cunliffe WJ. Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure. Br J Dermatol. 1989;121:51-7.
3. Simpson N. Antibiotics in acne: time for a rethink. Br J Dermatol. 2001;144:225-7.
4. Coates P, Vyarknam S, Eady EA, et al. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 2002;146:840-8.
5. Bettoli V, Borghi A, Rossi R, Ferroni M, Rigolin F, Virgili A. Antibiotic resistance of propionibacteria. Dermatology. 2006;212:206-7.
6. Lehmann HP, Robinson KA, Andrews JS, Halloway V, Goodman SN. Acne therapy: A methodologic review. J Am Acad Dermatol. 2002;47:231-0.
7. Lucchina LC, Kollias N, Gillies R, et al. Fluorescence photography in the evaluation of acne. J Am Acad Dermatol. 1996;35:58-63.
8. Pagnoni AM, Kligman A. Digital fluorescence photography can assess the suppressive effect of benzoyl peroxide on Propionibacterium aches. J Am Acad Dermatol. 1999;41:710-6.
9. Rizova E, Kligman A. New photographic techniques for clinical evaluation of acne. J Eur Acad Dermatol Venereol. 2001;15(Suppl. 3):13-8.
10. Martin FJ, Kahn G, Gooding JW. Cutaneous porphyrin fluorescence as an indicator of antibiotic absorption and effectiveness. Cutis. 1973;12:758-64.
11. Leyden JJ. Antibiotic resistant acne. Cutis. 1976;17:593-6.
12. Eady EA, Gloor M, Leyden JJ. Propionibacterium aches resistance - a world wide problem. Dermatology. 2003;203:54-6.
13. Mills O, Thornsberry C, Cardin CW, et al. Bacterial resistance and therapeutic outcome following three months of topical acne therapy with 2% erythromycin gel versus its vehicle. Acta Derm Venereol. 2002;82:260-5.
14. Tan H-H. Topical antibacterial treatments for acne vulgaris. Am J Clin Dermatol. 2004;5:79-84.
15. Jappe U. Pathological mechanisms of acne with special emphasis on Propionibacetrium aches and related therapy. Acta Derm Venereol. 2003;83:241-8.
16. Sedlock DM, Bailey DM. Microbicidial activity of octenidine hydrochloride, a new alkanediylbis[pyridine] germicidal agent. Antimicrob Agents Chemother. 1985;28:786-90.
17. Dettenkofer M, Jonas D, Wiechmann C, Rossner R, Frank U, Zentner J, Daschner FD. Effect of skin disinfection with octenidine dihydrochloride on insertion site colonization of intravascular catheters. Infection. 2002;30:282-5.
18. Mc Ginley KJ, Webster GF, Leyden JL. Facial follicular porphyrin fluorescence: correlation with age and density of Propionibacterium acnes. Br J Dermatol. 1980;102:437-41.
19. Burkhart, CN. Digital fluorescence as a parameter of Propionibacterium acnes suppression needs assessment. Int J Dermatol. 2001;40:101-3.
20. Haider A, Shaw JC. Treatment of acne vulgaris. JAMA. 2004;292:726-35
21. Ozolines M, Eady EA, Avery AJ, et al. Comparison of five antimicrobial regimens for treatment of mild to moderate inflammatory facial acne vulgaris in the community: randomised controlled trial. Lancet. 2004;364:2188-95.